Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
PR Newswire Asia
BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing..
BEIJING and SHANGHAI and CHICAGO, June 2, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing..
· Phase III ASC4FIRST trial met both primary endpoints with clinically meaningful and statistically significant results;..
*Derek Neilson, head of the Agricultural Segment at CNH, to step down*
Basildon, May 30, 2024
CNH Industrial..